Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000152906 | SCV000167502 | benign | not specified | 2011-07-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000152906 | SCV000202333 | benign | not specified | 2013-12-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000152906 | SCV000305453 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000243277 | SCV000317535 | benign | Cardiovascular phenotype | 2015-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000470155 | SCV000562930 | benign | Long QT syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811998 | SCV002049844 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001811998 | SCV005234727 | benign | not provided | criteria provided, single submitter | not provided |